Effects of SLC22A2 808G>T polymorphism and bosutinib concentrations on serum creatinine in patients with chronic myeloid leukemia receiving bosutinib therapy
Abstract The purpose of this study was to investigate the effects of SLC22A2 808G>T polymorphism and trough concentrations (C0) of bosutinib on serum creatinine in 28 patients taking bosutinib. At 1, 3, 6, 12, 24, and 36 months after administration, analysis of bosutinib C0 and creatinine was per...
Guardado en:
Autores principales: | Maiko Abumiya, Naoto Takahashi, Saori Takahashi, Tomoko Yoshioka, Yoshihiro Kameoka, Masatomo Miura |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/cddf7025ea95456eac4b8a2a0965cf7f |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Structural and spectroscopic analysis of the kinase inhibitor bosutinib and an isomer of bosutinib binding to the Abl tyrosine kinase domain.
por: Nicholas M Levinson, et al.
Publicado: (2012) -
Bosutinib in the management of chronic myelogenous leukemia
por: Keller-von Amsberg G, et al.
Publicado: (2013) -
Comparing Therapeutic Focused Ultrasound (tfUS) in Conjunction with Bosutinib versus Independent tfUS Administration Among Alzheimer’s Patients
por: Margaret Zielinski, et al.
Publicado: (2021) -
Acta Nº808
por: Banco Central de Chile
Publicado: (2019) -
Low creatinine levels in diabetes mellitus among older individuals: the Yuport Medical Checkup Center Study
por: Saori Kashima, et al.
Publicado: (2021)